|
Name |
Trichodermamide A
|
| Molecular Formula | C20H20N2O9 | |
| IUPAC Name* |
(4aS,5R,8R,8aS)-N-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide
|
|
| SMILES |
COC1=C(C2=C(C=C1)C=C(C(=O)O2)NC(=O)C3=NO[C@H]4[C@@H](C=C[C@H]([C@]4(C3)O)O)O)OC
|
|
| InChI |
InChI=1S/C20H20N2O9/c1-28-13-5-3-9-7-10(19(26)30-15(9)16(13)29-2)21-18(25)11-8-20(27)14(24)6-4-12(23)17(20)31-22-11/h3-7,12,14,17,23-24,27H,8H2,1-2H3,(H,21,25)/t12-,14-,17+,20+/m1/s1
|
|
| InChIKey |
ZQOKLOPATOTAEE-OVCSSCHWSA-N
|
|
| Synonyms |
Trichodermamide A; (4aS,5R,8R,8aS)-N-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide; CHEMBL477717; DTXSID40894001; CHEBI:188558; Q63396565; 508218-11-9
|
|
| CAS | 508218-11-9 | |
| PubChem CID | 10982906 | |
| ChEMBL ID | CHEMBL477717 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 432.4 | ALogp: | -0.6 |
| HBD: | 4 | HBA: | 10 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 156.0 | Aromatic Rings: | 4 |
| Heavy Atoms: | 31 | QED Weighted: | 0.394 |
| Caco-2 Permeability: | -5.76 | MDCK Permeability: | 0.00003110 |
| Pgp-inhibitor: | 0.058 | Pgp-substrate: | 0.929 |
| Human Intestinal Absorption (HIA): | 0.768 | 20% Bioavailability (F20%): | 0.519 |
| 30% Bioavailability (F30%): | 0.992 |
| Blood-Brain-Barrier Penetration (BBB): | 0.444 | Plasma Protein Binding (PPB): | 63.22% |
| Volume Distribution (VD): | 1.013 | Fu: | 23.72% |
| CYP1A2-inhibitor: | 0.049 | CYP1A2-substrate: | 0.963 |
| CYP2C19-inhibitor: | 0.034 | CYP2C19-substrate: | 0.135 |
| CYP2C9-inhibitor: | 0.009 | CYP2C9-substrate: | 0.324 |
| CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.369 |
| CYP3A4-inhibitor: | 0.054 | CYP3A4-substrate: | 0.077 |
| Clearance (CL): | 1.583 | Half-life (T1/2): | 0.373 |
| hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.735 |
| Drug-inuced Liver Injury (DILI): | 0.977 | AMES Toxicity: | 0.179 |
| Rat Oral Acute Toxicity: | 0.245 | Maximum Recommended Daily Dose: | 0.063 |
| Skin Sensitization: | 0.101 | Carcinogencity: | 0.128 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
| Respiratory Toxicity: | 0.536 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004309 | ![]() |
0.792 | D08SKH | ![]() |
0.294 | ||
| ENC002524 | ![]() |
0.776 | D06GCK | ![]() |
0.281 | ||
| ENC002347 | ![]() |
0.617 | D03DIG | ![]() |
0.274 | ||
| ENC003738 | ![]() |
0.413 | D0Q0PR | ![]() |
0.273 | ||
| ENC003545 | ![]() |
0.406 | D0W8WB | ![]() |
0.272 | ||
| ENC003659 | ![]() |
0.405 | D0L1JW | ![]() |
0.267 | ||
| ENC003540 | ![]() |
0.397 | D09DHY | ![]() |
0.267 | ||
| ENC003539 | ![]() |
0.394 | D0E6OC | ![]() |
0.264 | ||
| ENC004276 | ![]() |
0.387 | D07MGA | ![]() |
0.256 | ||
| ENC004280 | ![]() |
0.379 | D0G4KG | ![]() |
0.252 | ||